Imaging Sciences & Biomedical Engineering (Research Division)

|

MPhil/PhD

|

Part Time, Full Time

Medicine graduate class
RESEARCH PROFILE
  • 2008 RAE Result: 75 per cent of research activity in the Division was rated as world leading or internationally excellent.
  • Research income: The expansion of the Division's research capacity over the last 5 years is reflected in the growth of competitively won research income which has increased to over £40m in 2011/12. This is primarily due to the award of a number of strategic grants, and the creation of two new research departments in Biomedical Engineering and Perinatal Imaging and Health.
  • Current number of academic staff: 70.
  • Current number of research students: 100.
  • Recent publications: Papers have been published in the Lancet, Nature Medicine, Magnetic Resonance Medicine, Journal of Bone & Mineral Research, Medical Image Analysis, Journal of Medicinal Chemistry, Circulation, Dalton Transactions.
  • Current research projects:
    • Wellcome/EPSRC- Medical Engineering Centre
    • CRUK/EPSRC Comprehensive Cancer Imaging Centre
    • Grand Challenges: Translating Biomedical Modelling into the Heart of the Clinic
    • euHEART: Personalised & Integrated Cardiac Care: Patient-specific Cardiovascular Modelling and Simulation for In Silico Disease Understanding & Management and for Medical Device Evaluation & Optimization
    • HYPERImage: Hybrid PET-MR system for concurrent ultra-sensitive imaging
    • Virtual Anatomy Trainer for Minimal Access Surgery (VATMAS)
    • Magnetic Resonance Guided Therapy of Cardiac Arrhythmia (MaRGiTA)
    • NCRI: PET Research Network
    • Quantitative assessment of with intravascular contrast agents
    • Small animal pet imaging for translational biomedical research
    • Electrophysiology Platform for Image-Guided Arrhythmia Management (EPIGRAM)
    • Time resolved whole-heart cardiac imaging using highly parallel magnetic resonance.
    • Electro-anatomical fusion for guiding EP procedures and patient-specific modelling and electrophysiology platform for image-guided arrhythmia management
    • New fluorine chemistry for PET (F-18) and MRI (F-19) imaging
    • Copper radionuclide complexes for PET imaging of hypoxia
    • PET Imaging of Thyroid Cancer with F-18 Labelled Tetrafluoroborate
    • MRI as an interventional tool in children with heart disease.
  • Partner organisations:
    • Philips Healthcare
    • Antisoma
    • Bayer Schering Pharma
    • Berlin Heart GmbH
    • Bracco
    • Bristol-Myers Squibb
    • Covidien Petten (Netherlands)
    • DOPPLER-CIP
    • EPIX-Medical
    • Ferropharm
    • GE Healthcare, Milwaukee, USA
    • GE Imanet
    • GE Uppsala
    • German Cancer Research Center
    • Hansen Medical
    • HemoLab BV
    • IXICO (Derek Hill)
    • Lantheus Medical Imaging
    • Miltenyi Biotec
    • Nordic NeuroLabs, Bergen, Norway
    • Novartis
    • Pfizer Central Research, Grotton, New York, USA
    • PolyDimensions GmbH
    • St. Jude Medical
    • Takeda Pharmaceuticals, Osaka Japan
    • Volcano Europe SA/NV
    • Academic Medical Centre, Amsterdam (Jos Spaan)
    • Aarhus, Denmark (Th. S. Sorensen)
    • Barts/Queen Mary
    • Cleveland Clinic (Scott Flamm)
    • Fremantle Australia (Re-188 therapy)
    • German Heart Institute Berlin (Titus Kühne, Inga Grünwald)
    • Harvard Medical School (Reza Nezafat, Warren Manning)
    • Hospital Clínico San Carlos de Madrid Insalud
    • Imperial College London (D. Rueckert, J. Hajnal)
    • INRIA, Nice (Nicolas Ayache)
    • INSERM, Rennes (Jean-Louis Coatrieux)
    • Institut für Herzinfarktforschung, Ludwigshafen (Jochen Senges)
    • Institute for Biomedical Engineering University and ETH Zurich (Sebastian Kozerke and Peter Boesiger)
    • Johns Hopkins (Nael Osman, Matthias Stuber)
    • Mannheim University of Applied Sciences (Ivo Wolf)
    • Mayo Clinic (Erik Ritman)
    • Medical College Wisconsin (Dan Beard)
    • Mediso, Budapest
    • Mie University (Hajime Sakuma)
    • NIBIB, NIH, Bethesda (Rod Pettigrew, Robert Lederman)
    • Oxford University (Nic Smith)
    • Santiago de Chile (P. Irarrázaval)
    • Skejby University Hospital, Aarhus (Yong Kim, T Sangild)
    • Technische Universität München (Markus Schwaiger)
    • The University of Sheffield (Rod Hose)
    • TU-Munich (M. Schwaiger)
    • University College London (Dave Hawkes), UCL Cancer Imaging centre
    • University of Auckland (Peter Hunter)
    • University of Bordeaux (Chrit Moonen)
    • University of Kent
    • University of Hull
    • University of Leeds (Sven Plein)
    • University of Leiden (Albert de Roos)
    • University Sao Paolo, Brazil
    • University of Sarawak, Malaysia (Annuar Rapaee)
    • University of Washington, Seattle (Chun Yuan)
    • Universitaet Karlsruhe (O. Doessel)
    • Universitat Pompeu Fabra, Barcelona (A. Frangi)
    • Washington University in St Louis (Sam Wickline, M Welsh).
KEY FACTS
Head of group/division
Professor Reza Razavi
Awarding institution
King's College London
Duration
Expected to be three years FT or up to six years PT. Registration normally October, although students may commence at any time. Some special studentships are four years FT.
Location
Guy's, St Thomas', Waterloo and Strand campuses.
Student destinations
Students go onto have a wide and varied career in academia, NHS and in industry.
Year of entry 2013
Offered by
No results found
Guy's Campus